Antiviral activities of individual murine IFN-alpha subtypes in vivo: intramuscular injection of IFN expression constructs reduces cytomegalovirus replication
- PMID: 9510197
Antiviral activities of individual murine IFN-alpha subtypes in vivo: intramuscular injection of IFN expression constructs reduces cytomegalovirus replication
Abstract
The IFN-alpha cytokines belong to a multigene family. However, the in vivo biological functions of each of the IFN-alpha subtypes is unknown. Recently, we developed an experimental model in which the tibialis anterior muscles of mice were transfected in situ with naked DNA plasmids encoding an IFN transgene. Here we use this model to investigate the in vivo effect of the expression of three murine IFN-alpha subtypes (A1, A4, and A9) on murine CMV replication in C57BL/6, BALB/c, and A/J mice. CMV was shown to replicate in the tibialis anterior muscles of mice for at least 6 days and induced an inflammatory infiltrate. However, mice expressing the IFN-alpha transgenes showed a marked reduction in the peak titers of virus replication, with less severe inflammation in the muscles compared with control mice that were inoculated with blank vectors. Moreover, mice expressing the IFN-alpha1 transgene had significantly lower CMV titers in the inoculated muscle than mice expressing either the IFN-alpha4 or the IFN-alpha9 transgenes. Furthermore, IFN-alpha/beta receptor knockout mice had markedly higher levels of CMV replication in the tibialis anterior muscles than the wild-type parental strain (129/Sv/Ev) following IFN-alpha1 transgene inoculation, suggesting that the protection observed is due to host cell-mediated IFN signaling. These data provide the first evidence indicating that there are in vivo differences in the antiviral efficacy of the IFN-alpha subtypes.
Similar articles
-
In vivo expression of an interferon-alpha gene by intramuscular injection of naked DNA.J Interferon Cytokine Res. 1997 May;17(5):255-61. doi: 10.1089/jir.1997.17.255. J Interferon Cytokine Res. 1997. PMID: 9181463
-
Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice.Gene Ther. 2002 Oct;9(20):1369-78. doi: 10.1038/sj.gt.3301809. Gene Ther. 2002. PMID: 12365002
-
The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection.Eur J Immunol. 2009 Apr;39(4):1007-18. doi: 10.1002/eji.200838814. Eur J Immunol. 2009. PMID: 19283778
-
Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection.Immunol Cell Biol. 2002 Oct;80(5):425-35. doi: 10.1046/j.1440-1711.2002.01103.x. Immunol Cell Biol. 2002. PMID: 12225378
-
Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection.Curr Eye Res. 2000 May;20(5):405-12. Curr Eye Res. 2000. PMID: 10855035
Cited by
-
Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis.Immunology. 2002 Jul;106(3):428-37. doi: 10.1046/j.1365-2567.2002.01423.x. Immunology. 2002. PMID: 12100732 Free PMC article.
-
Anti-tumor effect of pEgr-IFNgamma gene-radiotherapy in B16 melanoma-bearing mice.World J Gastroenterol. 2004 Oct 15;10(20):3011-5. doi: 10.3748/wjg.v10.i20.3011. World J Gastroenterol. 2004. PMID: 15378784 Free PMC article.
-
Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes.Retrovirology. 2011 Sep 26;8:75. doi: 10.1186/1742-4690-8-75. Retrovirology. 2011. PMID: 21943056 Free PMC article.
-
A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon alpha.Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1553-8. doi: 10.1073/pnas.96.4.1553. Proc Natl Acad Sci U S A. 1999. PMID: 9990062 Free PMC article.
-
Direct application of plasmid DNA containing type I interferon transgenes to vaginal mucosa inhibits HSV-2 mediated mortality.Biol Proced Online. 2006;8:55-62. doi: 10.1251/bpo118. Epub 2006 Jun 14. Biol Proced Online. 2006. PMID: 16900260 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical